ES2191982T3 - Derivados de 6-o-alquilo de eritronolida b. - Google Patents

Derivados de 6-o-alquilo de eritronolida b.

Info

Publication number
ES2191982T3
ES2191982T3 ES98959480T ES98959480T ES2191982T3 ES 2191982 T3 ES2191982 T3 ES 2191982T3 ES 98959480 T ES98959480 T ES 98959480T ES 98959480 T ES98959480 T ES 98959480T ES 2191982 T3 ES2191982 T3 ES 2191982T3
Authority
ES
Spain
Prior art keywords
derivatives
eritronolida
rent
alkyl derivatives
erythronolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98959480T
Other languages
English (en)
Inventor
Howard E Gracey
Stephen H Montgomery
David A Riley
Jih-Hua Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2191982T3 publication Critical patent/ES2191982T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención se refiere a derivados de eritromicina. Más en particular, la presente invención se refiere a derivados 6-O-alquilo de eritronolida B y a procesos para la preparación de derivados 6-O- alquilo de eritronolida B.
ES98959480T 1997-12-01 1998-11-17 Derivados de 6-o-alquilo de eritronolida b. Expired - Lifetime ES2191982T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/980,919 US5919916A (en) 1997-12-01 1997-12-01 6-O-alkyl derivatives of erythronolide B

Publications (1)

Publication Number Publication Date
ES2191982T3 true ES2191982T3 (es) 2003-09-16

Family

ID=25527957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98959480T Expired - Lifetime ES2191982T3 (es) 1997-12-01 1998-11-17 Derivados de 6-o-alquilo de eritronolida b.

Country Status (13)

Country Link
US (1) US5919916A (es)
EP (1) EP1040107B1 (es)
JP (1) JP2001524549A (es)
KR (1) KR20010032636A (es)
AT (1) ATE231851T1 (es)
AU (1) AU1526899A (es)
CA (1) CA2309977A1 (es)
DE (1) DE69811120T2 (es)
DK (1) DK1040107T3 (es)
ES (1) ES2191982T3 (es)
IL (1) IL135792A0 (es)
PT (1) PT1040107E (es)
WO (1) WO1999028311A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
EP1313486A1 (en) * 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7825200B2 (en) * 2003-02-28 2010-11-02 The Regents Of The University Of California Controlled free radical grafting from polyolefins
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JP5602748B2 (ja) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ，インコーポレイテッド トリアゾール含有マクロライドを用いた生体防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH08149986A (ja) * 1994-09-28 1996-06-11 Taisho Pharmaceut Co Ltd １２−ヒドロキシ−６−ｏ−アルキルエリスロマイシン及びその類縁体の製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
CA2309977A1 (en) 1999-06-10
JP2001524549A (ja) 2001-12-04
AU1526899A (en) 1999-06-16
EP1040107B1 (en) 2003-01-29
DK1040107T3 (da) 2003-05-05
KR20010032636A (ko) 2001-04-25
US5919916A (en) 1999-07-06
WO1999028311A1 (en) 1999-06-10
IL135792A0 (en) 2001-05-20
DE69811120D1 (de) 2003-03-06
EP1040107A1 (en) 2000-10-04
PT1040107E (pt) 2003-06-30
DE69811120T2 (de) 2003-10-09
ATE231851T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
ES2191982T3 (es) Derivados de 6-o-alquilo de eritronolida b.
DK0891371T3 (da) 9-oximsilylerythromycin A derivater
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
PT86800A (pt) Process for the preparation of erythromycin derivatives
AU7067087A (en) Improved process for preparing macrolide derivatives
DK1015466T3 (da) Derivater af 9-hydrazon og 9-azinerythromycin og en fremgangsmåde til fremstilling af samme
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
EP0846697A4 (en) PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES
NO903780D0 (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
KR970702922A (ko) 독소루비신의 제조방법(Process for preparing doxorubicin)
PT88493A (pt) Process for preparing milbemycin derivatives useful as antiparasitic agents
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
HUP9801428A3 (en) Process for preparing prostaglandin e1, e2 and analogs thereof using furylcopper reagents
IS1853B (is) Ný aðferð til að búa til 3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíð
NO952676D0 (no) Fremgangsmåte for fremstilling av pumpbare vandige leireblandinger
NO903196L (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
DZ1435A1 (fr) Synthèse asymétrique des dérivés de la furo Ä3,4-cÜpyridine.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
AU5067399A (en) Process for the preparation of erythromycin derivatives
NO881848L (no) Skjult innledning for frekvenshoppet synkronisering.
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi